92 related articles for article (PubMed ID: 24300467)
1. Molecular portraits of heterogeneity related to cancer stem cells in human ovarian cancer.
Zeng J; Ruan J; Luo L; Shi J; Cui Q; Yang J; Shen K
Int J Gynecol Cancer; 2014 Jan; 24(1):29-35. PubMed ID: 24300467
[TBL] [Abstract][Full Text] [Related]
2. Is sphere assay useful for the identification of cancer initiating cells of the ovary?
Martínez-Serrano MJ; Caballero-Baños M; Vilella R; Vidal L; Pahisa J; Martínez-Roman S
Int J Gynecol Cancer; 2015 Jan; 25(1):12-7. PubMed ID: 25365589
[TBL] [Abstract][Full Text] [Related]
3. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S
Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
[TBL] [Abstract][Full Text] [Related]
5. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
6. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
7. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo.
Nagare RP; Sneha S; Krishnapriya S; Ramachandran B; Murhekar K; Vasudevan S; Shabna A; Ganesan TS
Exp Cell Res; 2020 Jul; 392(1):112009. PubMed ID: 32305326
[TBL] [Abstract][Full Text] [Related]
8. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma.
Bartakova A; Michalova K; Presl J; Vlasak P; Kostun J; Bouda J
J Obstet Gynaecol; 2018 Jan; 38(1):110-114. PubMed ID: 28816557
[TBL] [Abstract][Full Text] [Related]
9. Expression of nestin in ovarian serous cancer and its clinicopathologic significance.
He QZ; Luo XZ; Zhou Q; Wang K; Li SX; Li Y; Zhu HT; Duan T
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2896-901. PubMed ID: 24254558
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
11. [Expression Level of Membrane-associated Proteins Numb in Epithelial Ovarian Carcinoma and Its Relationship with Ovarian Cancer Stem Cell Markers CD117, CD133, ALDH1.].
Jing H; Liu XY; Chen YL; Bai LP; Zheng A
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):878-882. PubMed ID: 28598117
[TBL] [Abstract][Full Text] [Related]
12. S100B promotes chemoresistance in ovarian cancer stem cells by regulating p53.
Yang T; Cheng J; You J; Yan B; Liu H; Li F
Oncol Rep; 2018 Sep; 40(3):1574-1582. PubMed ID: 29956807
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
14. [Detection of cancer stem cells in ovarian cancer].
Bartáková A; Pecková K; Daum O; Bouda J
Ceska Gynekol; 2014 Jan; 79(1):7-11. PubMed ID: 24635358
[TBL] [Abstract][Full Text] [Related]
15. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
17. DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancers.
Kim KH; Kang YJ; Jo JO; Ock MS; Moon SH; Suh DS; Yoon MS; Park ES; Jeong N; Eo WK; Kim HY; Cha HJ
Biochem Biophys Res Commun; 2014 May; 447(2):315-22. PubMed ID: 24727449
[TBL] [Abstract][Full Text] [Related]
18. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.
Karmakar S; Seshacharyulu P; Lakshmanan I; Vaz AP; Chugh S; Sheinin YM; Mahapatra S; Batra SK; Ponnusamy MP
Oncotarget; 2017 Feb; 8(9):14806-14820. PubMed ID: 28122356
[TBL] [Abstract][Full Text] [Related]
19. Establishment of human ovarian serous carcinomas cell lines in serum free media.
Pan Z; Hooley J; Smith DH; Young P; Roberts PE; Mather JP
Methods; 2012 Mar; 56(3):432-9. PubMed ID: 22445873
[TBL] [Abstract][Full Text] [Related]
20. Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Sato M; Kawana K; Adachi K; Fujimoto A; Taguchi A; Fujikawa T; Yoshida M; Nakamura H; Nishida H; Inoue T; Ogishima J; Eguchi S; Yamashita A; Tomio K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Osuga Y; Fujii T
Oncol Rep; 2017 Mar; 37(3):1883-1888. PubMed ID: 28112360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
